Results 251 to 260 of about 114,159 (384)

Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario

open access: yesThe Laryngoscope, EarlyView.
The uptake of MAiD for head and neck cancer (HNC) has been steadily increasing since 2016, when MAiD first became available in Canada. Our study projects a substantial increase in the future use of MAiD for patients with HNC. As such, our health system needs to re‐evaluate and implement the necessary infrastructure to support the projected increase in ...
Tanika Curry   +8 more
wiley   +1 more source

Transoral Robotic Surgical Resection of Bilateral Parapharyngeal Space Rhabdomyoma. [PDF]

open access: yesCase Rep Otolaryngol
Brady JS   +4 more
europepmc   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Localization and expression of TRPV1 and TRPA1 in the human oropharynx and larynx

open access: yesNeurogastroenterology and Motility, 2016
D. Álvarez-Berdugo   +9 more
semanticscholar   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan   +4 more
wiley   +1 more source

Assessment of impairment of intelligibility and of speech signal after oral cavity and oropharynx cancer

open access: green, 2019
Mathieu Balaguer   +5 more
openalex   +2 more sources

Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial. [PDF]

open access: yesCurr Oncol
Yamashita G   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy